TrialClinical interventions in aging2015

Safety of daily teriparatide treatment: a post hoc analysis of a Phase III study to investigate the possible association of teriparatide treatment with calcium homeostasis in patients with serum procollagen type I N-terminal propeptide elevation.

Takanori Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.